Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for Prevention of Acute Mountain Sickness
NCT01665781Phase 4Completed
- Sponsor
- University of Ulsan
- Start
- Aug 2012
- Primary completion
- Mar 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of erythropoietin in acute mountain sickness (AMS) (2 arms), sponsored by University of Ulsan. Primary endpoint: Acute mountain sickness score. Started Aug 2012; status: completed.
02
Drugs
erythropoietin
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT01665781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01665781.